Last reviewed · How we verify

NCT07280975: PolySuture

Comparing Polyglactin vs Polypropylene Sutures for Rectus Sheath Closure

Not yet recruiting NA Last updated 15 December 2025
What this trial tests

NA trial testing Polyglactin 910 (Vicryl) Suture in Chronic Pain in 156 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
30 June 2027
30 July 2027

Quick facts

Lead sponsorLady Reading Hospital, Pakistan
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment156
Start date1 April 2026
Primary completion30 June 2027
Estimated completion30 July 2027
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Lady Reading Hospital, Pakistan

Who can join

Adults 18 to 70, any sex, with Chronic Pain or Wound Dehiscence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to compare the outcomes of Polyglactin (Vicryl) versus Polypropylene (Prolene) sutures for rectus sheath closure in patients undergoing midline laparotomy. The study will evaluate the rates of incisional hernia, surgical site infection (SSI), wound dehiscence, chronic pain, and suture sinus formation. Participants aged 18-70 years, undergoing either elective or emergency laparotomy, will be randomly assigned to receive either Polyglactin or Polypropylene sutures. The primary outcome measure is the incidence of incisional hernia at 6 months, with secondary outcomes including SSI, wound complications, and chronic pain. The study is particularly important in the context of Pakistan, where such comparative data is limited, and aims to provide evidence-based recommendations for optimal suture material selection in general surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Lady Reading Hospital, Pakistan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07280975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing